文献速递慢性肾脏病

慢性肾脏病中与蛋白尿相关的血清代谢组学改变

Serum Metabolomic Alterations Associated with Proteinuria in CKD.
PubMed 文献 · Clin J Am Soc Nephrol · 2019-02-07

本研究利用AASK(n=962)和MDRD(n=620)两项临床试验的储存血清,采用非靶向代谢组学分析蛋白尿与637种已知代谢物的横断面关联。在Bonferroni校正后,共发现58种血清代谢物与蛋白尿显著相关,其中4种同时与ESKD风险相关。

要点

  • 在CKD人群中识别出58种与蛋白尿相关的血清代谢物。
  • 磷脂酰乙醇胺通路中所有6种定量代谢物均与蛋白尿显著相关。
  • 4种代谢物与蛋白尿相关的同时也与ESKD风险相关。

核心结论

  • 在AASK和MDRD研究人群中,共发现58种血清代谢物与蛋白尿存在横断面关联。
  • 部分与蛋白尿相关的代谢物同时也与CKD进展(ESKD)相关。

研究设计与样本

  • 采用AASK(n=962)和MDRD(n=620)两项临床试验的储存血清样本进行非靶向代谢组学分析。
  • 评估尿蛋白肌酐比值与637种已知非药物代谢物的横断面关联,并校正关键临床协变量。
  • 对与蛋白尿显著相关的代谢物进一步检验其与CKD进展的关联。

主要发现

  • AASK研究中位尿蛋白肌酐比为80(IQR 28-359)mg/g,MDRD研究为188(IQR 54-894)mg/g。
  • AASK平均年龄56岁,女性占39%,黑人占100%,中位GFR为48(IQR 35-57)ml/min/1.73m²。
  • MDRD平均年龄52岁,女性占38%,黑人占7%,中位GFR为28(IQR 18-39)ml/min/1.73m²。
  • 线性回归在Bonferroni校正(P<7.8×10⁻⁵)后识别出66种代谢物与蛋白尿相关,其中58种在荟萃分析中显著(P<7.8×10⁻⁴)。
  • P值最低(P<10⁻²⁷)的代谢物为4-羟基百菌清和1,5-脱水葡萄糖醇,磷脂酰乙醇胺通路所有6种定量代谢物均显著。

临床怎么用

  • 这些代谢物可能作为蛋白尿相关CKD进展的生物标志物,但需进一步验证。
  • 磷脂酰乙醇胺通路代谢物与蛋白尿的强关联提示其潜在病理生理意义。

局限性

  • 研究为横断面设计,无法推断因果关系。
  • 代谢物关联基于两项临床试验人群,外推性需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Data are scarce on blood metabolite associations with proteinuria, a strong risk factor for adverse kidney outcomes. We sought to investigate associations of proteinuria with serum metabolites identified using untargeted profiling in populations with CKD. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Using stored serum samples from the African American Study of Kidney Disease and Hypertension (AASK; n=962) and the Modification of Diet in Renal Disease (MDRD) study (n=620), two rigorously conducted clinical trials with per-protocol measures of 24-hour proteinuria and GFR, we evaluated cross-sectional associations between urine protein-to-creatinine ratio and 637 known, nondrug metabolites, adjusting for key clinical covariables. Metabolites significantly associated with proteinuria were tested for associations with CKD progression. RESULTS: In the AASK and the MDRD study, respectively, the median urine protein-to-creatinine ratio was 80 (interquartile range [IQR], 28-359) and 188 (IQR, 54-894) mg/g, mean age was 56 and 52 years, 39% and 38% were women, 100% and 7% were black, and median measured GFR was 48 (IQR, 35-57) and 28 (IQR, 18-39) ml/min per 1.73 m2. Linear regression identified 66 serum metabolites associated with proteinuria in one or both studies after Bonferroni correction (P<7.8×10-5), 58 of which were statistically significant in a meta-analysis (P<7.8×10-4). The metabolites with the lowest P values (P<10-27) were 4-hydroxychlorthalonil and 1,5-anhydroglucitol; all six quantified metabolites in the phosphatidylethanolamine pathway were also significant. Of the 58 metabolites associated with proteinuria, four were associated with ESKD in both the AASK and the MDRD study. CONCLUSIONS: We identified 58 serum metabolites with cross-sectional associations with proteinuria, some of which were also associated with CKD progression. PODCAST: This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2019_02_07_CJASNPodcast_19_03_.mp3.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Luo S, Coresh J, Tin A, et al. Serum Metabolomic Alterations Associated with Proteinuria in CKD. Clin J Am Soc Nephrol. 2019. PMID: 30733224. doi:10.2215/CJN.10010818

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。